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Fully covered metal stents eters  of  25,  20,  and  24  mm,  respectively,  was  placed  in  all
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wfor the treatment of leaks
after esophagogastric oncologic
surgery
Prótesis metálicas totalmente cubiertas para
el tratamiento de las fugas después de cirugía
oncológica esófago-gástrica
Anastomotic  leaks  present  in  8.3  to  5.9%  of  patients  after
esophagectomy  and  gastrectomy,  respectively.1 Saliva  and
gastric  juice  leakage  into  the  mediastinum  is  responsible  for
30-40%  of  postoperative  deaths.1 The  use  of  self-expanding
metal  stents  has  been  reported  to  aid  in  cicatrization  and
reduce  mortality.2 The  aim  of  this  report  was  to  present  our
experience  in  7  cases  of  postoperative  leakage  after  esoph-
agogastric  oncologic  surgery  treated  through  fully  covered
self-expanding  metal  stents  (FCSEMSs).
Between  January  2013  and  October  2014,  7  patients
with  postoperative  leakage  were  treated  (Table  1).  Four
were  men  and  3  were  women  and  their  ages  ranged
from  30  to  64  years.  The  etiologic  diagnosis  was  can-
cer  of  the  gastroesophageal  junction  in  2  patients,  gastric
adenocarcinoma  in  4,  and  esophageal  adenocarcinoma  in
one  patient.  All  the  patients  were  candidates  for  surgi-
cal  resection.  Esophagojejunal  anastomosis  was  the  surgical
reconstruction  performed  in  5  patients  and  esophagogas-
tric  anastomosis  was  performed  in  2.  During  the  endoscopic
check-up,  the  approximate  anastomotic  defect  percentage
was  calculated  as  follows:  ¼  of  the  circumference  =  25%,  ½
=  50%,  and  ¾ =75%.  The  endoscopic  study  revealed  defects
at  the  level  of  the  anastomosis  of  <  25  to  70%  of  the  cir-
cumference  (Fig.  1).  The  time  lapse  between  the  surgery
and  diagnosis  of  the  leak  was  from  4  to  20  days  and  it  varied
from  5  to  40  days  between  the  surgery  and  stent  placement.
A  FCSEMS  (SX-ELLA  Stent  Esophageal  HV,  Czech  Republic)
with  an  85  mm  length  and  distal,  mid,  and  proximal  diam-
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t  was  a  silicone-covered  nitinol  stent.  Six  of  the  7  patients
ad  immediate  occlusion  of  the  leak  after  contrast  medium
nstillation  under  ﬂuoroscopic  control  (Fig.  1). Leakage  out-
ut  stopped  within  24  h  after  stent  placement  in  6  patients
nd  was  conﬁrmed  clinically  and  through  a  barium  swallow
Fig.  1).  Oral  diet  was  begun  1-3  days  after  stent  placement
n  5  patients,  one  patient  received  parenteral  nutrition  due
o  a  swallowing  disorder  secondary  to  a cerebral  hemor-
hage,  and  one  patient  had  surgical  reintervention  without
eginning  the  oral  diet.  The  FCSEMSs  were  removed  using
onventional  biopsy  forceps,  putting  pressure  on  the  stent
oop.  The  stents  were  easily  removed  with  no  complications
7-40  days  after  placement  in  6  patients.  Endoscopic  check-
p  and  barium  swallow  showed  no  evidence  of  leakage  after
tent  removal.  There  was  one  case  of  partial  stent  displace-
ent,  but  it  continued  to  cover  the  leakage  site.  Granulation
issue  was  found  in  the  same  patient  at  the  distal  end  of  the
tent.  The  stent  covering  was  undamaged  at  the  time  of
xtraction  in  6  of  the  7  patients.  We  had  no  stent-related
omplications  or  deaths.
Important  considerations  in  the  treatments  of  leaks
nclude  their  etiology,  size,  and  the  clinical  condition  of
he  patient.  Different  studies  have  shown  the  feasibility  of
lacing  self-expanding  metal  stents  in  patients  with  ana-
tomotic  leakage  that  would  otherwise  require  a surgical
ntervention.2--4 In  our  cases,  clinical  success  reached  85.7%,
oinciding  with  other  studies  that  have  reported  success
ates  of  48-100%,  with  no  difference  between  the  result
nd  the  type  of  stent  used.5--9 Studies  in  animals  suggest
hat  stent  placement  for  30  days  is  sufﬁcient  for  tissue
icatrization.10 In  our  patients,  the  stents  were  in  place
or  27-40  days,  a  length  of  time  similar  to  that  of  a  pre-
ious  study.10 With  respect  to  the  precise  time  for  stent
lacement,  some  authors  favor  placement  within  24  h  of
eak  diagnosis  to  limit  contamination  of  the  cavity  and
romote  cicatrization.1,10 However,  there  have  also  been
eports  stating  that  late  placement  can  result  in  closure  of
he  anastomotic  leak.1,6 In  our  short  experience,  the  stents
ere  removed  5  to  32  days  after  surgery  and  cicatrization
as  achieved  in  6  of  the  7 patients.  One  report  suggests  that
o  be  successful,  the  leaks  should  be  smaller  than  70%  of  the
ircumference  of  the  anastomosis  and  there  should  be  no
schemia.1 Our  ﬁndings  were  similar,  except  in  one  patient
ith  25%  dehiscence  of  the  anastomosis.  In  that  case  the
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Table  1  Patient  characteristics  and  results.
Patients  1  2  3  4  5  6  7
Age  64  59  49  54  49  30  56
Sex Man  Man  Woman  Man  Woman  Woman  Man
Tumor GEJ  cancer  EAC  GAC  GEJ  cancer  GAC  GAC  GAC
Type of
anastomosis
EJA  EGA  EJA  EGA  EYA  EYA  EYA
Percentage
of
dehiscence
of the
anastomosis
25%  50%  70%  <25%  25%  25%  50%
PO day  of
leak
diagnosis
9  8  5  16  20  4  8
PO day  of
stent
placement
14  40  20  18  32  5  21
Commencement
of oral  diet
(after  stent)
2  1  1  ------  3  ------  3
Days with
stent
31  30  33  40  28  2  27
Pre-stent
treatment Antibiotic
EN
Antibiotic
PN
Antibiotic
PNAntibiotic  PN
Antibiotic
Antibiotic  PN
Antibiotic
Result Cure Cure  Cure  Cure  Cure  QR-Death  Cure
EAC: esophageal adenocarcinoma; EGA: esophagogastric anastomosis; EJA: esophagojejunal anastomosis; EN: enteral nutrition; GAC:
gastric adenocarcinoma; GEJ: gastroesophageal junction; PN: parenteral nutrition; PO: postoperative; QR: surgical reintervention
<25% of the
circumference
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sigure  1  A)  The  endoscopic  image  shows  the  leakage  site.
eakage.
eak  became  larger  after  stent  placement,  which  was  doc-
mented  through  tomography,  and  the  patient  underwent
urgical  reintervention.
FCSEMS  placement  appears  to  be  a  feasible  and  less
nvasive  option  in  patients  with  postoperative  leaks  after
sophagogastric  oncologic  surgery.  We  used  a  stent  with
 larger  distal  diameter  and  a  proximal  ring  designed  to
revent  migration.  Such  characteristics  can  be  useful  in
atients  with  postoperative  leaks.  It  is  important  to  con-
ider  surgical  reintervention  when  there  are  unsatisfactory
esults.
C
The  x-ray  shows  the  esophageal  stent  with  no  contrast  agent
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